GLP-1 Dose Titration Guide
Semaglutide & Tirzepatide · 9 min read
Titration is the single most important factor in whether you tolerate GLP-1 therapy or quit in the first month. Both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are started at low doses and gradually increased over weeks to months. Go too fast, and you get hit with nausea, vomiting, and fatigue that can feel unbearable. Go too slow, and you may not see the results you are looking for. This guide walks through the standard schedules, when to increase, when to hold, and when to step back down.
What Is Titration?
Titration means starting a medication at a low dose and increasing it gradually until you reach a therapeutic level. For GLP-1 receptor agonists, titration serves two purposes: it lets your GI system adapt to delayed gastric emptying (the main driver of nausea), and it allows your prescriber to find the lowest effective dose for your body. Not everyone needs the maximum dose to get strong results.
Why you can't skip titration
Starting at a full therapeutic dose (semaglutide 2.4 mg or tirzepatide 15 mg) without titration would cause severe nausea and vomiting in the majority of users. The STEP and SURMOUNT trials used mandatory titration for all participants. There is no clinical evidence supporting skipping the ramp-up phase.
Semaglutide Titration Schedule
The standard schedule below is based on the Wegovy (weight management) labeling. Ozempic uses the same molecule but is approved for type 2 diabetes with a slightly different dose ceiling. Compounded semaglutide follows the same titration steps.
| Step | Dose | Duration | Notes |
|---|---|---|---|
| 1 | 0.25 mg/week | 4 weeks | Starting dose. Minimal weight loss expected. Focus on tolerability. |
| 2 | 0.5 mg/week | 4 weeks | First real therapeutic dose. Most users start noticing appetite suppression. |
| 3 | 1.0 mg/week | 4 weeks | Many users achieve good results here. Consider holding if weight loss is steady. |
| 4 | 1.7 mg/week | 4 weeks | Significant appetite suppression. GI side effects often increase at this step. |
| 5 | 2.4 mg/week | Maintenance | Maximum approved dose (Wegovy). Not everyone needs to reach this level. |
Ozempic maximum dose is 2.0 mg/week. The 0.25 → 0.5 → 1.0 → 2.0 mg schedule applies for the diabetes indication.
Tirzepatide Titration Schedule
Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist with more titration steps and a higher dose ceiling than semaglutide. The SURMOUNT-1 trial demonstrated up to 22.5% body weight loss at the 15 mg dose.
| Step | Dose | Duration | Notes |
|---|---|---|---|
| 1 | 2.5 mg/week | 4 weeks | Starting dose. Establishes GI tolerance. Some appetite suppression begins. |
| 2 | 5.0 mg/week | 4 weeks | First therapeutic dose. Noticeable appetite reduction for most users. |
| 3 | 7.5 mg/week | 4 weeks | Strong appetite suppression. Many users find their effective dose here. |
| 4 | 10.0 mg/week | 4 weeks | Significant weight loss. GI side effects may increase at this step. |
| 5 | 12.5 mg/week | 4 weeks | High dose. Assess whether additional increase is needed based on results. |
| 6 | 15.0 mg/week | Maintenance | Maximum approved dose. Strongest effect but most GI burden. |
When to Titrate Up vs. Hold
The standard schedules show the minimum time at each dose (4 weeks). But minimum does not mean optimal. Here is how to decide whether to increase, hold, or reduce.
Signs you're ready to titrate up
- You've been at your current dose for at least 4 weeks with no significant GI side effects
- Weight loss has stalled or slowed significantly (less than 1 lb/week for 2+ consecutive weeks)
- Appetite suppression has noticeably weakened and you are feeling hungrier between meals
- Your prescriber agrees the increase is appropriate based on your progress and labs
Signs you should hold your current dose
- You are still losing weight at a steady rate (even if slower than the first few weeks)
- You are managing side effects but they haven't fully resolved yet
- Appetite suppression is still working and you are consistently eating less than before
- You are hitting your protein targets and training consistently at this dose level
- You are within 10–15 lbs of your goal weight (a lower dose may be sufficient for maintenance)
When to Titrate Down
Titrating down is underutilized. Many users and even some prescribers treat the dose as a one-way ramp, but reducing your dose is a legitimate and often smart clinical decision.
Persistent severe nausea or vomiting
If GI side effects haven't improved after 6-8 weeks at a dose, step back. Staying miserable leads to discontinuation, which is worse than a slower titration.
Inability to eat enough protein
If appetite suppression is so strong that you consistently can't hit 1 g/lb of protein despite shakes and low-volume meals, a lower dose may produce better body composition outcomes.
Excessive weight loss rate
Losing more than 1.5-2% of body weight per week increases lean mass loss disproportionately. Slowing down the rate preserves more muscle.
Approaching goal weight
As you near your target, a lower maintenance dose often provides sufficient appetite control with fewer side effects and lower cost.
Compounded vs. Brand Dosing Differences
Compounded semaglutide and tirzepatide use the same active molecule as the brand-name pens but come in multi-dose vials at various concentrations. The titration doses are identical, but the logistics differ.
Brand pens
- Pre-filled, fixed-dose pens (one click = one dose)
- No reconstitution or math required
- Easier to use, harder to dose-split
- More expensive ($800–1,300/month without insurance)
Compounded vials
- Multi-dose vials, typically 5 mg/mL or 10 mg/mL
- Requires insulin syringes and volume calculation
- Allows micro-dosing and custom titration steps
- Significantly cheaper ($100–350/month typical)
Compounded dosing advantage: custom titration
With compounded vials, you can make intermediate titration steps that aren't available with brand pens. For example, instead of jumping from 0.5 mg to 1.0 mg semaglutide, you can do 0.5 → 0.75 → 1.0 mg. This gentler ramp can reduce side effects significantly. Use our reconstitution calculator to get the exact syringe volume for any dose.
Common Titration Mistakes
Most titration problems are avoidable. Here are the mistakes we see most often.
Titrating too fast
Most commonIncreasing before completing the minimum 4 weeks at a dose, or increasing despite unresolved side effects. The desire for faster results is understandable, but GI side effects compound at higher doses. Users who titrate too fast are far more likely to discontinue therapy entirely.
Skipping doses to manage side effects
Some users skip a week when they feel nauseous, then resume at the same dose. This creates inconsistent drug levels and can actually worsen side effects when you restart. If a dose is intolerable, reduce it rather than skipping. Consistent, lower dosing is better than intermittent higher dosing.
Chasing the maximum dose
The maximum dose (semaglutide 2.4 mg, tirzepatide 15 mg) is not the goal. It's the ceiling. If you are losing weight steadily at 1.0 mg semaglutide or 7.5 mg tirzepatide, you may never need to go higher. Higher doses mean more side effects, more muscle loss risk, and higher cost, with diminishing additional weight loss.
Changing injection day without adjusting
Moving your injection day by more than 1–2 days can create uneven drug levels. If you need to change your injection day, shift it by one day at a time over several weeks. Never take two doses closer than 3 days apart.
Ignoring nutrition during titration
Many users focus entirely on the dose and neglect the fundamentals: adequate protein, hydration, and electrolytes. Side effects are significantly worse when you are dehydrated or under-eating. Nail the nutrition basics before blaming the dose.
FAQ
Titration is the process of gradually increasing your dose over time rather than starting at the full therapeutic dose. GLP-1 drugs require titration because starting at a high dose causes severe nausea and vomiting in most people. By slowly increasing the dose, your body adapts to the GI effects at each level before moving to the next.
Absolutely. The standard titration schedule shows the maximum dose, not a required target. If you are losing weight steadily and tolerating your current dose well, there is no clinical reason to increase. Many people achieve excellent results on semaglutide 1.0 mg or tirzepatide 5-7.5 mg without ever reaching the top dose. Discuss with your provider.
If you miss one weekly dose, take it as soon as you remember (as long as your next dose is at least 2 days away). If you miss two or more consecutive weeks, contact your prescriber. You may need to restart at a lower dose rather than resuming where you left off, especially if you've been off for 4+ weeks.
Compounded semaglutide uses the same active molecule but comes in different concentrations (often 5 mg/mL or 10 mg/mL vials). The titration doses are the same, but you are drawing a specific volume from a vial rather than using a pre-filled pen with fixed doses. This requires careful reconstitution math. Use our calculator to verify your syringe units.
The minimum recommended time at each dose is 4 weeks. Even if you feel fine, your body needs time to adapt at a receptor level. Titrating faster than 4 weeks significantly increases the risk of severe side effects hitting suddenly at higher doses. Patience during titration leads to better long-term adherence.
Step back to the previous dose you tolerated well and stay there for another 4-6 weeks before attempting to increase again. This is standard clinical practice and not a failure. Some people also benefit from a half-step approach: for example, alternating between 0.5 mg and 1.0 mg weekly before committing to 1.0 mg every week. Discuss options with your prescriber.
Explore GLP-1 Protocols & Tools
Read our detailed dosing protocols, manage your side effects, or calculate your exact reconstitution and syringe units.